BRICK, N.J., Sept. 20, 2016 /PRNewswire/ -- Sathish Reddy, President and CEO of Theranostix Inc., today announced the formation of P4 Diagnostix™, a specialized diagnostic laboratory.
Theranostix Inc. acquired Platinum Pathology and Long Island Pathology earlier this year. The laboratories are now unified under the name of P4 Diagnostix™. Each laboratory will focus its service offerings to form centers of excellence for individual specialties of urology, gastroenterology, dermatology, podiatry and women's health.
"The landscape of the anatomic pathology laboratory industry has changed significantly over the past few years," said Reddy. "These changes have forced laboratories to quickly adapt in order to maintain growth while providing quality sub-specialized diagnostics. P4 has implemented a unique IT infrastructure allowing our laboratories to achieve better economies of scale without compromising on quality and service offerings."
P4 endeavors to move beyond the basic service of providing a diagnosis, but instead impact medicine on a larger scale by allowing physicians to become more focused on each patient's individualized care. The better prediction and prevention of disease will rely on expansive research and insight. The first step is to diagnose disease, then access and integrate critical information for physician-driven decisions necessary to enhance wellness.
P4 Diagnostix™ will continue to reinvent the way that laboratories interact with physicians in order to improve outcomes through quality testing, unique service offerings and robust IT solutions. The company's headquarters are located in Brick, NJ.
About P4 Diagnostix™
P4 Diagnostix™ incorporates three laboratory companies, including Theranostix, Inc. (Beltsville, MD and Brick, NJ), Long Island Pathology, Inc. (East Setauket, NY) and Platinum Pathology, LLC (Glen Allen, VA). P4 represents a progressive pathway in healthcare focused on predictive, preventative, personalized and participatory medical practice, beyond the practice of diagnosing and treating disease. P4 Diagnostix™ has multiple centers of excellence: molecular diagnostics, urology, gastroenterology, dermatology, women's health, podiatry, and general surgical pathology. Notably, as a specialized diagnostic company, P4 Diagnostix™ provides broad access to national insurance contracts. P4 Diagnostix's progressive integration of diagnostic testing and office workflow is rooted in partnership with VitalAxis, Inc., an industry leader in the delivery of healthcare informatics. Today, VitalAxis serves more than 10,000 physicians, including over 5,000 urologists and in excess of 100,000 end users. For more information on how P4 is improving outcomes, please visit www.P4Dx.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/launch-of-p4-diagnostix-300330346.html
SOURCE P4 Diagnostix